Editorial Comment.

Abstract

No AccessJournal of UrologyAdult Urology13 Apr 2023Editorial CommentThis article comments on the following:Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging–targeted Biopsy: A Study That Challenges the Dogmais a letter which has replyReply by Authors Christoph Würnschimmel, Philipp Baumeister, and Agostino Mattei Christoph WürnschimmelChristoph Würnschimmel Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland Faculty of Medicine and Health Sciences, University of Lucerne, Lucerne, Switzerland More articles by this author , Philipp BaumeisterPhilipp Baumeister Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland Faculty of Medicine and Health Sciences, University of Lucerne, Lucerne, Switzerland More articles by this author , and Agostino MatteiAgostino Mattei Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland Faculty of Medicine and Health Sciences, University of Lucerne, Lucerne, Switzerland More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003442.01AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookLinked InTwitterEmail "Editorial Comment." The Journal of Urology, Publish Ahead of Print, pp. – REFERENCES 1. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol.2006; 50(5):1006-1013. Crossref, Medline, Google Scholar 2. Unilateral pelvic lymph node dissection in prostate cancer patients diagnosed in the era of magnetic resonance imaging–targeted biopsy: a study that challenges the dogma. J Urol2023; 210(1):000-000. Google Scholar 3. The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. Eur Urol.2008; 53(1):118-125. Crossref, Medline, Google Scholar 4. Extended versus limited pelvic lymph node dissection during radical prostatectomy for intermediate- and high-risk prostate cancer: early oncological outcomes from a randomized phase 3 trial. Eur Urol.2021; 79(5):595-604. Crossref, Medline, Google Scholar © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology13 Apr 2023Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging–targeted Biopsy: A Study That Challenges the DogmaJournal of Urology13 Apr 2023Reply by Authors Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Christoph Würnschimmel Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland Faculty of Medicine and Health Sciences, University of Lucerne, Lucerne, Switzerland More articles by this author Philipp Baumeister Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland Faculty of Medicine and Health Sciences, University of Lucerne, Lucerne, Switzerland More articles by this author Agostino Mattei Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland Faculty of Medicine and Health Sciences, University of Lucerne, Lucerne, Switzerland More articles by this author Expand All Advertisement PDF downloadLoading ...